Keiichiro Ohta

Title: Keiichiro Ohta: Innovator in Anti-Peptic Ulcer Agents

Introduction

Keiichiro Ohta is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-peptic ulcer agents. His innovative approach combines various materials to create effective treatments for peptic ulcers.

Latest Patents

Ohta holds a patent for an anti-peptic ulcer agent. This agent comprises a powdery material that includes tocopheryl retinoate, light silicic anhydride, and an antioxidant. Additionally, it contains a low substituted hydroxypropylcellulose and polyvinylpyrrolidone, which is orally administrable. This formulation showcases Ohta's commitment to advancing medical treatments.

Career Highlights

Keiichiro Ohta is associated with Lederle (Japan), Ltd., where he has been instrumental in research and development. His work has led to the creation of innovative solutions that address critical health issues. Ohta's dedication to improving patient outcomes is evident in his research endeavors.

Collaborations

Ohta has collaborated with Masaaki Kurihara, contributing to the advancement of their shared goals in pharmaceutical innovation. Their partnership highlights the importance of teamwork in achieving breakthroughs in medical science.

Conclusion

Keiichiro Ohta's contributions to the field of anti-peptic ulcer agents demonstrate his innovative spirit and commitment to healthcare. His work continues to impact the pharmaceutical industry positively.